PROGRAF 1 MG

About

PROGRAF 1 MG contains Tacrolimus, a potent calcineurin inhibitor widely utilized as an immunosuppressant to prevent organ rejection in transplant recipients. Its mechanism involves binding to an intracellular protein, FKBP-12, forming a complex that inhibits calcineurin. Calcineurin is a phosphatase enzyme critical for the activation of T-lymphocytes, as it dephosphorylates nuclear factor of activated T-cells (NFAT), allowing its translocation into the nucleus to initiate gene transcription for cytokine production, such as interleukin-2 (IL-2). By blocking this pathway, tacrolimus effectively suppresses T-cell activation and proliferation, thereby preventing the immune system from mounting an attack against the transplanted organ.

Tacrolimus is a cornerstone of most modern immunosuppressive regimens due to its high efficacy in reducing the incidence of acute rejection episodes and improving long-term graft survival rates across various solid organ transplants. Careful therapeutic drug monitoring is essential to optimize dosing and minimize toxicity.

Uses

• Prevention of kidney transplant rejection.
• Prevention of liver transplant rejection.
• Prevention of heart transplant rejection.
• Treatment of organ rejection refractory to other immunosuppressants.

Directions For Use

Take orally, usually twice daily, on an empty stomach for consistent absorption. Follow precise dosing instructions from your healthcare provider.

Benefits

• Highly effective in preventing organ rejection.
• Improves long-term graft survival rates.
• Reduces the incidence of acute rejection episodes.
• Allows for lower doses of corticosteroids.
• Available in various formulations (oral, IV, topical).
• Well-established in transplant medicine.

Side Effects

• Nephrotoxicity
• Neurotoxicity (tremor, headache, insomnia)
• Hyperglycemia
• Hypertension
• Hyperkalemia
• Gastrointestinal disturbances (nausea, diarrhea)
• Increased risk of infection
• Increased risk of malignancy
• Alopecia
• Anemia
• Peripheral edema
• Paresthesia

Safety Measures

• Alcohol - Avoid or limit alcohol due to potential for increased liver toxicity and exacerbation of side effects.
• Pregnancy - Use only if the potential benefit justifies the potential risk to the fetus; associated with increased risk of prematurity and low birth weight.
• Breastfeeding - Not recommended during breastfeeding as it is excreted into breast milk and can cause serious adverse effects in the infant.
• Liver - Use with extreme caution in patients with severe liver impairment; dose adjustments are often necessary due to altered metabolism.
• Kidney - Nephrotoxic; monitor kidney function closely and adjust dose as needed to prevent or manage renal dysfunction.
• Lung - Increased risk of opportunistic infections, including pulmonary infections; monitor for respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.